EC-18 is a synthetic monoacetyldiaglyceride (1-palmitoyl-2-linoleoyl-3-acetylglycerol).
We investigated effects of EC-18 on lung inflammation induced by cigarette smoke and LPS in vivo.
EC-18 reduced the inflammatory cell count and proinflammatory mediators.
EC-18 suppressed airway inflammation and NF-κB activation.
EC-18 may be a therapeutic agent for chronic obstructive pulmonary disease.